New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Re...( DALLAS March 5 /- A study published...),Health

DALLAS, March 5 /PRNewswire/ -- A study published by Deborah S. Sarnoff, M.D. et al in the February issue of the Journal of Drugs in Dermatology explores the new generation of carbon dioxide (CO2) laser skin resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes a fractional or microablative approach to treating the skin allowing for rapid healing, less downtime and profound results. Dr. Sarnoff is a board certified dermatologist and clinical professor of Dermatology at NYU Medical Center.

As consumers have become savvier to skin care and laser options, the pendulum is swinging back to more result-oriented treatments. With the saturation of non-ablative lasers, skin tightening devices and chemical peels, patients are looking for an alternative treatment that offers exceptional results with fewer treatments and less time in the doctor's office. What these procedures can do in 4-5 treatments, the DOT technology can do in a single treatment and results have been far superior to anything on the market today.

By combining the CO2 laser with a fractionated technique, the latest innovation in skin rejuvenation, DOT (Dermal Optical Thermolysis), has become the optimal choice for active patients desiring significant effects from a single treatment with minimal downtime. Additionally, DOT Therapy is ideal in causing immediate contraction of wrinkles and loose skin, results that non-ablative lasers produce in a time span of about six months.

Dr. Sarnoff's study examined 32 patients ages 33-76 over a six-month period who underwent a single laser resurfacing procedure with the DOT technology. Areas treated included the face, neck, trunk and hands. Results demonstrated over 50% improvement in almost all of the patients. Those treated for wrinkles, hyperpigmentation and sun damage showed over 75% improvement.

Why It Works

The D
'/>"/>